Feb 19 (Reuters) - Swiss dental implant maker Straumann
STMN.S on Wednesday forecast 2025 sales growth in the high
single-digit percentage range, as it expects the overall patient
flow to be positive.
It reported 13.7% organic revenue growth to 2.50 billion
Swiss francs ($2.77 billion) in 2024, compared to the analysts'
average forecast of 2.49 billion francs in a poll compiled by
Vara Research.
($1 = 0.9027 Swiss francs)
(Reporting by Bartosz Dabrowski in Gdansk; Editing by
Muralikumar Anantharaman)
((bartosz.dabrowski@thomsonreuters.com;))